Subjective Outcome

Peptides for joint pain

7 compoundsin Regimen’s catalog are configured to track joint pain via Rate Today. Each one shows the dose range, listed benefits, and every outcome it’s set up to monitor. Tap through to plan a dose with the free reconstitution calculator.

7 compounds

BPC-157

Body Protective Compound

Peptide

A synthetic peptide with potent tissue-healing, gut-protective, and anti-inflammatory properties. Widely used for injury recovery and gut health.

  • Accelerated tendon and ligament healing
  • Reduced joint pain and inflammation
  • Improved gut health

Tracks

Joint painEnergy

TB-500

Thymosin Beta-4 fragment

Peptide

Synthetic 17–amino-acid fragment of the naturally occurring Thymosin Beta-4 protein. Drives actin polymerization, accelerates wound and soft-tissue repair, and modulates inflammation through actin sequestration in injured tissue.

  • Soft-tissue and tendon repair
  • Reduced inflammation at injury site
  • Improved range of motion in chronic injury

Tracks

Joint painEnergy

BPC-157 + TB-500

Peptide

Tracks

Joint painEnergy

GLOW-70

GHK-Cu / BPC-157 / TB-500

Peptide

A regenerative peptide blend targeting skin quality, tissue repair, and systemic recovery.

  • Improved skin elasticity and texture
  • Accelerated tissue and wound healing
  • Reduced inflammation

Tracks

Joint painEnergy

Thymulin

Zinc-bound Thymic Immunomodulator

Peptide

A nonapeptide secreted by thymic epithelial cells that requires zinc for biological activity. Studied for T-cell maturation, NF-κB suppression, and dampening of pro-inflammatory cytokines, primarily in animal models.

  • Modulates T-cell differentiation (preclinical)
  • Suppresses NF-κB and pro-inflammatory cytokines
  • Reduces TNF-α in LPS-stimulated macrophages

Tracks

Joint painEnergy

KPV

α-MSH C-terminal Anti-Inflammatory Tripeptide

Peptide

A tripeptide corresponding to the C-terminal fragment of α-melanocyte-stimulating hormone (Lys-Pro-Val). Anti-inflammatory in vitro and in vivo via PepT1-mediated cellular uptake (not melanocortin receptor signaling), with nanomolar inhibition of NF-κB and MAP kinase pathways.

  • Inhibits NF-κB and MAP kinase signaling
  • Reduces pro-inflammatory cytokine secretion
  • Reduced disease severity in DSS/TNBS colitis models

Tracks

Joint pain

KLOW

KPV / GHK-Cu / BPC-157 / TB-500

Peptide

A regenerative, anti-inflammatory peptide blend that adds KPV to the GLOW base (GHK-Cu, BPC-157, TB-500) for extra immune and gut-inflammation support alongside skin quality and tissue repair.

  • Improved skin elasticity and texture
  • Accelerated tissue and wound healing
  • Reduced systemic and gut inflammation

Tracks

Joint painEnergy

Other outcomes